請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73098
標題: | 臺灣兒童用藥安全與醫師開立處方行為之評估:系統動態學之觀點 Evaluating Pediatric Drug Safety and Prescribing Behavior in Taiwan:A System Dynamics Approach |
作者: | Yi-Rou Lei 雷沂柔 |
指導教授: | 余峻瑜(Jiun-Yu Yu) |
關鍵字: | 系統動態學,兒童用藥安全,醫師開方行為,小兒磨粉,兒童專用藥, System Dynamics,Pediatric Drug Safety,Pulverized Medicine,Prescribing Behavior,Pediatric Drug Formulation, |
出版年 : | 2019 |
學位: | 碩士 |
摘要: | Drug formulation used in pediatric patients should be appropriate, safe, as well as be adapted to children’s needs. The use of inadequate drug formulation and the pulverizing medicine phenomenon are widespread in Taiwan. Many existing treatments are not suitable for children, which often leads to medical malpractice. Although the advocacy of pediatric drug safety from non-government organization, the improving regulations from government regarding current clinical situations remain stagnant. In order to evaluate the pediatric drug safety issue, this essay uses system dynamics approach to analyze the results that come from different prescribing behaviors. The analyses found out problems generated from pulverized medicine caused drug safety, drug efficacy, and cost issues, causing the decrease of the relative safety and efficacy of treatment, illustrated by balancing loops in the system dynamics. On the other hand, the reinforcing loops in the system dynamics generated from pediatric drug formulations created incentives to drive doctors to prescribe more pediatric drug formulations, leading to better drug safety and drug efficacy of treatment for children. Therefore, the system dynamics depicts the whole structure of pediatric drug safety issue came from different prescribing behaviors, letting us have a clear picture to address this problem. Four key issues that need to be addressed to stimulate the further improvement for pediatric drug safety in the medical system are identified: (1) building the network of medical institutions to promote pediatric safety; (2) set up online platforms and use of existing data to transmit more medication knowledge; (3) collect more clinical feedback and patients’ outcome to improve the development and the utilization of pediatric drug formulation (4) take the responsibility of saving more medical resources, helping government to save the cost in order to address drug safety and many other issues. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73098 |
DOI: | 10.6342/NTU201901332 |
全文授權: | 有償授權 |
顯示於系所單位: | 管理學院企業管理專班(Global MBA) |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 4.07 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。